共 50 条
A case of atypical hemolytic uremic syndrome in a second renal transplant
被引:1
|作者:
Zwang, Nicholas A.
[1
,2
,5
]
Ho, Bing
[1
]
Kanwar, Yashpal S.
[3
]
Lewis, Brad
[4
]
Cusick, Matthew
[1
]
Friedewald, John J.
[1
,2
,3
,4
,5
]
Gallon, Lorenzo
[1
]
机构:
[1] Northwestern Univ, Feinberg Sch Med, Comprehens Transplant Ctr, Chicago, IL 60611 USA
[2] Northwestern Univ, Mcgaw Med Ctr, Chicago, IL 60611 USA
[3] Northwestern Mem Hosp, Dept Pathol, Chicago, IL 60611 USA
[4] Machaon Diagnost, Oakland, CA USA
[5] Northwestern Mem Hosp, Arkes Family Pavil Suite 1900,676N St Clair, Chicago, IL 60611 USA
关键词:
Kidney transplantation;
Graft failure;
Atypical hemolytic uremic syndrome;
Histocompatibility;
Complement biology;
CYCLOSPORINE-SIROLIMUS COMBINATION;
THROMBOTIC MICROANGIOPATHY;
KIDNEY-TRANSPLANTATION;
FACTOR-I;
COMPLEMENT;
MUTATIONS;
ECULIZUMAB;
EXPRESSION;
INHIBITOR;
ANTIBODY;
D O I:
10.1007/s40620-016-0373-7
中图分类号:
R5 [内科学];
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号:
1002 ;
100201 ;
摘要:
Atypical hemolytic uremic syndrome (aHUS) has gained increased visibility over several years as an important cause of renal failure. Unfortunately, diagnosis is often difficult because individual courses can be highly variable depending the causative genetic mutations. Here we present the case of a patient with a failed renal allograft and acute failure of a second allograft who was ultimately diagnosed with aHUS. Interestingly, he developed early de novo donor specific antibodies (DSA) after the second renal transplant in context of likely recurrent aHUS. Terminal complement inhibition with eculizumab resulted in prompt improvement of renal allograft function.
引用
收藏
页码:165 / 172
页数:8
相关论文